|
1
|
Xie Z, Zhang H, Tsai W, Zhang Y, Du Y,
Zhong J, Szpirer C, Zhu M, Cao X, Barton MC, et al: Zinc finger
protein ZBTB20 is a key repressor of alpha-fetoprotein gene
transcription in liver. Proc Natl Acad Sci USA. 105:10859–10864.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang W, Mi J, Li N, Sui L, Wan T, Zhang
J, Chen T and Cao X: Identification and characterization of DPZF, a
novel human BTB/POZ zinc finger protein sharing homology to BCL-6.
Biochem Biophys Res Commun. 282:1067–1073. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sutherland AP, Zhang H, Zhang Y, Michaud
M, Xie Z, Patti ME, Grusby MJ and Zhang WJ: Zinc finger protein
Zbtb20 is essential for postnatal survival and glucose homeostasis.
Mol Cell Biol. 29:2804–2815. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mitchelmore C, Kjaerulff KM, Pedersen HC,
Nielsen JV, Rasmussen TE, Fisker MF, Finsen B, Pedersen KM and
Jensen NA: Characterization of two novel nuclear BTB/POZ domain
zinc finger isoforms. Association with differentiation of
hippocampal neurons, cerebellar granule cells, and macroglia. J
Biol Chem. 277:7598–7609. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nielsen JV, Blom JB, Noraberg J and Jensen
NA: Zbtb20-induced CA1 pyramidal neuron development and area
enlargement in the cerebral midline cortex of mice. Cereb Cortex.
20:1904–1914. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nielsen JV, Nielsen FH, Ismail R, Noraberg
J and Jensen NA: Hippocampus-like corticoneurogenesis induced by
two isoforms of the BTB-zinc finger gene Zbtb20 in mice.
Development. 134:1133–1140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF,
Tang L, Cao D, Zhang WP, Hu HP and Wang HY: Zinc finger protein
ZBTB20 expression is increased in hepatocellular carcinoma and
associated with poor prognosis. BMC Cancer. 11:2712011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kan H, Huang Y, Li X, Liu D, Chen J and
Shu M: Zinc finger protein ZBTB20 is an independent prognostic
marker and promotes tumor growth of human hepatocellular carcinoma
by repressing FoxO1. Oncotarget. 7:14336–14349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Zhou X, Zhang M, Cheng L, Zhang Y
and Wang X: ZBTB20 promotes cell migration and invasion of gastric
cancer by inhibiting IkappaBalpha to induce NF-κB activation. Artif
Cells Nanomed Biotechnol. 47:3862–3872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao JG, Ren KM and Tang J: Zinc finger
protein ZBTB20 promotes cell proliferation in non-small cell lung
cancer through repression of FoxO1. FEBS Lett. 588:4536–4542. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de la Rosa J, Weber J, Friedrich MJ, Li Y,
Rad L, Ponstingl H, Liang Q, de Quirós SB, Noorani I, Metzakopian
E, et al: A single-copy sleeping beauty transposon mutagenesis
screen identifies new PTEN-cooperating tumor suppressor genes. Nat
Genet. 49:730–741. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
de la Rosa J, Weber J, Rad R, Bradley A
and Cadinanos J: Disentangling PTEN-cooperating tumor suppressor
gene networks in cancer. Mol Cell Oncol. 4:e13255502017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lapointe S, Perry A and Butowski NA:
Primary brain tumours in adults. Lancet. 392:432–446. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 17
(Suppl 4):iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Jiang J, Hui X, Wang W, Fang D and
Ding L: Mir-758-5p suppresses glioblastoma proliferation, migration
and invasion by targeting ZBTB20. Cell Physiol Biochem.
48:2074–2083. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cancer Genome Atlas Research Network, .
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA,
Rheinbay E, Miller CR, Vitucci M, et al: Comprehensive, integrative
genomic analysis of diffuse lower-grade gliomas. N Engl J Med.
372:2481–2498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brennan CW, Verhaak RG, McKenna A, Campos
B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ,
Berman SH, et al: The somatic genomic landscape of glioblastoma.
Cell. 155:462–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Z, Zhang KN, Wang Q, Li G, Zeng F,
Zhang Y, Wu F, Chai R, Wang Z, Zhang C, et al: Chinese glioma
genome atlas (CGGA): A comprehensive resource with functional
genomic data from Chinese glioma patients. Genomics Proteomics
Bioinformatics. 19:1–12. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Orr BA, Haffner MC, Nelson WG,
Yegnasubramanian S and Eberhart CG: Decreased
5-hydroxymethylcytosine is associated with neural progenitor
phenotype in normal brain and shorter survival in malignant glioma.
PLoS One. 7:e410362012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang F, Liu Y, Zhang Z, Li J, Wan Y,
Zhang L, Wang Y, Li X, Xu Y, Fu X, et al: 5-hydroxymethylcytosine
loss is associated with poor prognosis for patients with WHO grade
II diffuse astrocytomas. Sci Rep. 6:208822016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnson KC, Houseman EA, King JE, von
Herrmann KM, Fadul CE and Christensen BC: 5-Hydroxymethylcytosine
localizes to enhancer elements and is associated with survival in
glioblastoma patients. Nat Commun. 7:131772016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Forloni M, Gupta R, Nagarajan A, Sun LS,
Dong Y, Pirazzoli V, Toki M, Wurtz A, Melnick MA, Kobayashi S, et
al: Oncogenic EGFR represses the TET1 DNA demethylase to induce
silencing of tumor suppressors in cancer cells. Cell Rep.
16:457–471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu BK and Brenner C: Suppression of
TET1-dependent DNA demethylation is essential for KRAS-mediated
transformation. Cell Rep. 9:1827–1840. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thakur S and Brenner C: KRAS-driven
miR-29b expression is required for tumor suppressor gene silencing.
Oncotarget. 8:74755–74766. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scaffidi C, Schmitz I, Zha J, Korsmeyer
SJ, Krammer PH and Peter ME: Differential modulation of apoptosis
sensitivity in CD95 type I and type II cells. J Biol Chem.
274:22532–22538. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Neumann L, Pforr C, Beaudouin J, Pappa A,
Fricker N, Krammer PH, Lavrik IN and Eils R: Dynamics within the
CD95 death-inducing signaling complex decide life and death of
cells. Mol Syst Biol. 6:3522010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ito S, D'Alessio AC, Taranova OV, Hong K,
Sowers LC and Zhang Y: Role of Tet proteins in 5mC to 5hmC
conversion, ES-cell self-renewal and inner cell mass specification.
Nature. 466:1129–1133. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q,
Ding J, Jia Y, Chen Z, Li L, et al: Tet-mediated formation of
5-carboxylcytosine and its excision by TDG in mammalian DNA.
Science. 333:1303–1307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ji J, You Q, Zhang J, Wang Y, Cheng J,
Huang X and Zhang Y: Downregulation of TET1 promotes glioma cell
proliferation and invasion by targeting Wnt/β-catenin pathway. Anal
Cell Pathol (Amst). 2021:89807112021.PubMed/NCBI
|
|
32
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lo HW: Targeting Ras-RAF-ERK and its
interactive pathways as a novel therapy for malignant gliomas. Curr
Cancer Drug Targets. 10:840–848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang F, Xu M, Wang S, Song L, Yu D, Li Y,
Cao R, Xiong Z, Chen Z, Zhang Q, et al: Gain-Of-function
E76K-mutant SHP2 promotes cell proliferation, metastasis, and tumor
growth in glioblastoma through activation of the ERK/CREB pathway.
Onco Targets Ther. 12:9435–9447. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang K, Luan L, Li X, Sun X and Yin J: ERK
inhibition in glioblastoma is associated with autophagy activation
and tumorigenesis suppression. J Neurooncol. 156:123–137. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gong R, Li H, Liu Y, Wang Y, Ge L, Shi L,
Wu G, Lyu J, Gu H and He L: Gab2 promotes acute myeloid leukemia
growth and migration through the SHP2-Erk-CREB signaling pathway. J
Leukoc Biol. 112:669–677. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen J, Li M and Min L: HSPB8 promotes
cancer cell growth by activating the ERK-CREB pathway and is
indicative of a poor prognosis in gastric cancer patients. Oncol
Rep. 39:2978–2986. 2018.PubMed/NCBI
|
|
38
|
Itoh N, Yonehara S, Ishii A, Yonehara M,
Mizushima S, Sameshima M, Hase A, Seto Y and Nagata S: The
polypeptide encoded by the cDNA for human cell surface antigen Fas
can mediate apoptosis. Cell. 66:233–243. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rokhlin OW, Glover RA and Cohen MB:
Fas-mediated apoptosis in human prostatic carcinoma cell lines
occurs via activation of caspase-8 and caspase-7. Cancer Res.
58:5870–5875. 1998.PubMed/NCBI
|
|
40
|
Pirnia F, Schneider E, Betticher DC and
Borner MM: Mitomycin C induces apoptosis and caspase-8 and −9
processing through a caspase-3 and Fas-independent pathway. Cell
Death Differ. 9:905–914. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Chun HJ, Wong W, Spencer DM and
Lenardo MJ: Caspase-10 is an initiator caspase in death receptor
signaling. Proc Natl Acad Sci USA. 98:13884–13888. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Suita H, Shinomiya T and Nagahara Y:
Caspase-6 induces 7A6 antigen localization to mitochondria during
FAS-induced apoptosis of Jurkat cells. Anticancer Res.
37:1697–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
